New User? Sign Up | Sign In

Insider Trading - XERIS PHARMACEUTICALS INC (XERS)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
XERS Insider Trading Transactions for XERIS PHARMACEUTICALS INC
Goto page 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-11-25
Purchase
2019-11-27
4:43 pm
XERIS PHARMACEUTICALS INC XERS Edick Paul R
Director
17,935 $8.547 $153,283 172,935
(Indirect
Direct)
View
2019-01-14
Sale
2019-10-16
4:27 pm
XERIS PHARMACEUTICALS INC XERS PRESTRELSKI STEVEN
Chief Scientific Officer
27,700 $12.01 $332,600 469,324
(Direct)
View
2019-04-11
Sale
2019-04-12
5:23 pm
XERIS PHARMACEUTICALS INC XERS PRESTRELSKI STEVEN
Chief Scientific Officer
10,000 $9.565 $95,649 477,024
(Direct)
View
2019-03-11
Purchase
2019-03-12
7:15 pm
XERIS PHARMACEUTICALS INC XERS Edick Paul R
Director
30,000 $9.12 $273,585 155,000
(Indirect
Direct)
View
2019-02-19
Purchase
2019-02-25
5:38 pm
XERIS PHARMACEUTICALS INC XERS JOHNSON KENNETH ERLAND
See Remarks
1,000 $10 $10,000 3,245
(Direct)
View
2019-02-19
Purchase
2019-02-22
8:18 pm
XERIS PHARMACEUTICALS INC XERS Deutsch Barry M.
See Remarks
5,000 $10 $50,000 28,292
(Direct)
View
2019-02-19
Purchase
2019-02-22
4:36 pm
XERIS PHARMACEUTICALS INC XERS Hecht Beth
See Remarks
2,500 $10 $25,000 2,500
(Direct)
View
2019-02-19
Purchase
2019-02-21
4:18 pm
XERIS PHARMACEUTICALS INC XERS Redmile Group LLC
Green Jeremy
10% Owner
588,000 $10 $5,880,000 3,000,642
(Indirect)
View
2019-02-08
Sale
2019-02-12
5:55 pm
XERIS PHARMACEUTICALS INC XERS Flynn James E
Deerfield Mgmt L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Special Situations Fund L.P.
Deerfield Mgmt III L.P.
Deerfield Private Design Fund III L.P.
10% Owner
7,241 $15.09 $109,251 1,498,666
(Indirect)
View
2019-02-05
Sale
2019-02-07
8:13 pm
XERIS PHARMACEUTICALS INC XERS Flynn James E
Deerfield Mgmt L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Special Situations Fund L.P.
Deerfield Mgmt III L.P.
Deerfield Private Design Fund III L.P.
10% Owner
14,807 $15.02 $222,443 1,498,666
(Indirect)
View
2019-01-28
Sale
2019-01-30
5:38 pm
XERIS PHARMACEUTICALS INC XERS Flynn James E
Deerfield Mgmt L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Special Situations Fund L.P.
Deerfield Mgmt III L.P.
Deerfield Private Design Fund III L.P.
10% Owner
7,038 $15.12 $106,448 1,498,666
(Indirect)
View
2019-01-23
Sale
2019-01-25
6:24 pm
XERIS PHARMACEUTICALS INC XERS Flynn James E
Deerfield Mgmt L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Special Situations Fund L.P.
Deerfield Mgmt III L.P.
Deerfield Private Design Fund III L.P.
10% Owner
114,444 $15.43 $1,766,193 1,498,666
(Indirect)
View
2019-01-11
Sale
2019-01-15
4:11 pm
XERIS PHARMACEUTICALS INC XERS PRESTRELSKI STEVEN
Chief Scientific Officer
2,300 $0 $0 487,024
(Direct)
View
2018-12-24
Sale
2019-01-02
6:25 pm
XERIS PHARMACEUTICALS INC XERS PRESTRELSKI STEVEN
Chief Scientific Officer
15,720 $15.82 $248,738 505,044
(Direct)
View
2018-06-25
Purchase
2018-06-27
4:58 pm
XERIS PHARMACEUTICALS INC XERS Flynn James E
Deerfield Mgmt L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Special Situations Fund L.P.
Deerfield Mgmt III L.P.
Deerfield Private Design Fund III L.P.
10% Owner
750,000 $15 $11,250,000 1,498,666
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-11-19
Gift
2019-11-20
4:44 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS PRESTRELSKI STEVEN
Chief Scientific Officer
17,500 $0 431,824
(Direct)
View
2019-09-30
Option Award
2019-10-02
5:12 pm
N/A
2029-09-30
XERIS PHARMACEUTICALS INC XERS Thierer Mark
Director
19,650 $9.83 19,650
(Direct)
View
2019-07-01
Option Award
2019-07-03
4:58 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS Hecht Beth
See Remarks
1,124 $9.72 3,928
(Direct)
View
2019-07-01
Option Award
2019-07-03
4:57 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS JOHNSON KENNETH ERLAND
See Remarks
174 $9.72 3,419
(Direct)
View
2019-07-01
Option Award
2019-07-03
4:57 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS Deutsch Barry M.
See Remarks
1,428 $9.72 29,720
(Direct)
View
2019-07-01
Option Award
2019-07-03
4:56 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS Shannon John Patrick Jr
See Remarks
1,138 $9.72 10,121
(Direct)
View
2019-02-27
Option Award
2019-03-01
4:40 pm
N/A
2029-02-27
XERIS PHARMACEUTICALS INC XERS Schmid John P.
Director
20,000 $10 20,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
4:39 pm
N/A
2029-02-27
XERIS PHARMACEUTICALS INC XERS HALKUFF DAWN
Director
20,000 $10 20,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
4:36 pm
N/A
2029-02-27
XERIS PHARMACEUTICALS INC XERS BORMANN-KENNEDY BARBARA-JEAN ANNE
Director
20,000 $10 20,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
4:36 pm
N/A
2029-02-27
XERIS PHARMACEUTICALS INC XERS SHERMAN JEFFREY W
Director
20,000 $10 20,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
4:36 pm
N/A
2029-02-27
XERIS PHARMACEUTICALS INC XERS PERSKY MARLA
Director
20,000 $10 20,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
4:35 pm
N/A
2029-02-27
XERIS PHARMACEUTICALS INC XERS RIGBY JONATHAN
Director
20,000 $10 20,000
(Direct)
View
2019-01-31
Option Award
2019-02-01
4:44 pm
N/A
2029-01-31
XERIS PHARMACEUTICALS INC XERS Deutsch Barry M.
See Remarks
25,000 $13.88 25,000
(Direct)
View
2019-01-31
Option Award
2019-02-01
4:43 pm
N/A
2029-01-31
XERIS PHARMACEUTICALS INC XERS PRESTRELSKI STEVEN
See Remarks
25,000 $13.88 25,000
(Direct)
View
2019-01-31
Option Award
2019-02-01
4:42 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS Edick Paul R
Director
125,000 $0 200,000
(Direct)
View
2019-01-31
Option Award
2019-02-01
4:42 pm
N/A
2029-01-31
XERIS PHARMACEUTICALS INC XERS Edick Paul R
Director
200,000 $13.88 200,000
(Direct)
View
2019-01-31
Option Award
2019-02-01
4:40 pm
N/A
2029-01-31
XERIS PHARMACEUTICALS INC XERS JOHNSON KENNETH ERLAND
See Remarks
32,500 $13.88 32,500
(Direct)
View
2019-01-31
Option Award
2019-02-01
4:38 pm
N/A
2029-01-31
XERIS PHARMACEUTICALS INC XERS Shannon John Patrick Jr
See Remarks
80,000 $13.88 80,000
(Direct)
View
2019-01-31
Option Award
2019-02-01
4:38 pm
N/A
2029-01-31
XERIS PHARMACEUTICALS INC XERS Hecht Beth
See Remarks
32,500 $13.88 32,500
(Direct)
View
2018-12-24
Exercise
2019-01-02
6:25 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS PRESTRELSKI STEVEN
Chief Scientific Officer
15,720 $1.19 505,044
(Direct)
View
2018-12-24
Exercise
2019-01-02
6:25 pm
N/A
2023-12-26
XERIS PHARMACEUTICALS INC XERS PRESTRELSKI STEVEN
Chief Scientific Officer
15,720 $1.19 505,044
(Direct)
View
2018-06-25
Conversion
2018-06-28
08:47 am
N/A
N/A
XERIS PHARMACEUTICALS INC XERS Palmetto Partners Ltd.
Palmetto Partners 2014 LP
Palmetto Partners 2015 LP
10% Owner
1,657,125 $0 0
(Direct)
View
2018-06-25
Conversion
2018-06-28
08:47 am
N/A
N/A
XERIS PHARMACEUTICALS INC XERS Palmetto Partners Ltd.
Palmetto Partners 2014 LP
Palmetto Partners 2015 LP
10% Owner
1,036,599 $0 0
(Direct)
View
2018-06-25
Conversion
2018-06-28
08:47 am
N/A
N/A
XERIS PHARMACEUTICALS INC XERS Palmetto Partners Ltd.
Palmetto Partners 2014 LP
Palmetto Partners 2015 LP
10% Owner
797,384 $0 0
(Direct)
View
2018-06-25
Conversion
2018-06-27
8:38 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS Edick Paul R
Director
13,430 $0 13,430
(Indirect)
View
2018-06-25
Conversion
2018-06-27
8:38 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS Edick Paul R
Director
23,922 $0 13,430
(Indirect)
View
2018-06-25
Conversion
2018-06-27
8:38 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS Deutsch Barry M.
CFO
2,238 $0 23,292
(Direct)
View
2018-06-25
Conversion
2018-06-27
8:38 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS Deutsch Barry M.
CFO
3,987 $0 23,292
(Direct)
View
2018-06-25
Conversion
2018-06-27
8:35 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS Shannon John Patrick Jr
See Remarks
8,983 $0 8,983
(Direct)
View
2018-06-25
Conversion
2018-06-27
8:35 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS Shannon John Patrick Jr
See Remarks
16,000 $0 8,983
(Direct)
View
2018-06-25
Conversion
2018-06-27
8:35 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS PRESTRELSKI STEVEN
Chief Scientific Officer
30,232 $0 489,323
(Direct)
View
2018-06-25
Conversion
2018-06-27
8:35 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS PRESTRELSKI STEVEN
Chief Scientific Officer
7,130 $0 489,323
(Direct)
View
2018-06-25
Conversion
2018-06-27
8:35 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS PRESTRELSKI STEVEN
Chief Scientific Officer
53,849 $0 489,323
(Direct)
View
2018-06-25
Conversion
2018-06-27
8:35 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS PRESTRELSKI STEVEN
Chief Scientific Officer
12,701 $0 489,323
(Direct)
View
2018-06-25
Conversion
2018-06-27
8:35 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS JOHNSON KENNETH ERLAND
See Remarks
2,245 $0 2,245
(Direct)
View
2018-06-25
Conversion
2018-06-27
8:35 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS JOHNSON KENNETH ERLAND
See Remarks
4,000 $0 2,245
(Direct)
View
2018-06-25
Conversion
2018-06-27
4:58 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS Flynn James E
Deerfield Mgmt L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Special Situations Fund L.P.
Deerfield Mgmt III L.P.
Deerfield Private Design Fund III L.P.
10% Owner
874,333 $0 1,498,666
(Indirect)
View
2018-06-25
Conversion
2018-06-27
4:58 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS Flynn James E
Deerfield Mgmt L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Special Situations Fund L.P.
Deerfield Mgmt III L.P.
Deerfield Private Design Fund III L.P.
10% Owner
874,333 $0 1,498,666
(Indirect)
View
2018-06-25
Conversion
2018-06-27
4:58 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS Flynn James E
Deerfield Mgmt L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Special Situations Fund L.P.
Deerfield Mgmt III L.P.
Deerfield Private Design Fund III L.P.
10% Owner
1,557,292 $0 1,498,666
(Indirect)
View
2018-06-25
Conversion
2018-06-27
4:58 pm
N/A
N/A
XERIS PHARMACEUTICALS INC XERS Flynn James E
Deerfield Mgmt L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Special Situations Fund L.P.
Deerfield Mgmt III L.P.
Deerfield Private Design Fund III L.P.
10% Owner
1,557,292 $0 1,498,666
(Indirect)
View
Goto page 0, 1, Next